Co-Authors
This is a "connection" page, showing publications co-authored by CHARLES F LEVENBACK and ANUJA JHINGRAN.
Connection Strength
0.534
-
Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol. 2008 Mar; 108(3):478-81.
Score: 0.077
-
Retroperitoneal lymph node resection in patients with cervical cancer. Surg Oncol. 2006 Aug; 15(2):79-83.
Score: 0.071
-
The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys. 2003 Oct 01; 57(2):409-18.
Score: 0.058
-
Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol. 2003 Sep; 90(3):625-8.
Score: 0.057
-
Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):1045-50.
Score: 0.027
-
Anatomic distribution of [(18)F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Pract Radiat Oncol. 2013 Jan-Mar; 3(1):45-53.
Score: 0.026
-
Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116. Int J Gynecol Cancer. 2011 Oct; 21(7):1266-75.
Score: 0.025
-
Concurrent chemoradiation in the routine management of patients with cervical cancer: does marital status matter? Int J Gynecol Cancer. 2009 Aug; 19(6):1107-12.
Score: 0.022
-
Evaluation of intervention to prevent hypomagnesemia in cervical cancer patients receiving combination cisplatin and radiation treatment. Support Care Cancer. 2009 Sep; 17(9):1195-201.
Score: 0.021
-
Predictive value of a proposed subclassification of stages I and II cervical cancer based on clinical tumor diameter. Int J Gynecol Cancer. 2009 Jan; 19(1):2-7.
Score: 0.021
-
Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys. 2008 Jan 01; 70(1):118-25.
Score: 0.019
-
Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1081-7.
Score: 0.018
-
Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix. Int J Gynecol Cancer. 2006 May-Jun; 16(3):1106-11.
Score: 0.017
-
Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005 Oct 20; 23(30):7428-36.
Score: 0.017
-
Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys. 2005 May 01; 62(1):138-47.
Score: 0.016
-
Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol. 2004 Apr; 93(1):27-33.
Score: 0.015
-
A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed m?llerian tumors with evaluation of potential molecular targets. Gynecol Oncol. 2003 Sep; 90(3):529-36.
Score: 0.014
-
Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol. 2002 Sep 01; 20(17):3651-7.
Score: 0.013